Longeveron (LGVN) Common Equity (2020 - 2026)

Longeveron's (LGVN) quarterly Common Equity came in at $16.0 million in Q1 2026, down 6.59% year-on-year from $17.2 million in Q1 2025, and up 182.41% quarter-over-quarter from $5.7 million in Q4 2025.

Longeveron (LGVN) Common Equity (2020 - 2026) Analysis & Trends

Longeveron's Common Equity history runs 7 years deep, the most recent figure standing at $16.0 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 6.59% year-over-year to $16.0 million in Q1 2026; TTM through Mar 2026 was $16.0 million, a 6.59% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, down 74.07% from the prior year.
  • Common Equity advanced to $16.0 million in Q1 2026 per LGVN's latest filing, from $5.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $34.3 million in Q1 2022 and bottomed at $3.0 million in Q1 2024.
  • The 5-year median for Common Equity is $16.0 million (2026), against an average of $16.3 million.
  • Across the five-year window, Common Equity plunged 81.36% in 2024 and jumped 464.22% in 2025, its largest moves.
  • Year by year, Common Equity stood at $20.5 million in 2022, then slumped by 67.12% to $6.7 million in 2023, then soared by 224.68% to $21.9 million in 2024, then slumped by 74.07% to $5.7 million in 2025, then soared by 182.41% to $16.0 million in 2026.
  • Per Business Quant, the three latest LGVN Common Equity figures stand at $16.0 million (Q1 2026), $5.7 million (Q4 2025), and $10.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 16.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.03 Mn
Dec 31, 2025 5.68 Mn
Sep 30, 2025 9.97 Mn
Jun 30, 2025 12.66 Mn
Mar 31, 2025 17.16 Mn
Dec 31, 2024 21.89 Mn
Sep 30, 2024 25.63 Mn
Jun 30, 2024 14.91 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 6.74 Mn
Sep 30, 2023 6.63 Mn
Jun 30, 2023 11.26 Mn
Mar 31, 2023 16.32 Mn
Dec 31, 2022 20.50 Mn
Sep 30, 2022 24.62 Mn
Jun 30, 2022 29.38 Mn
Mar 31, 2022 34.31 Mn
Dec 31, 2021 37.45 Mn
Dec 31, 2020 1.96 Mn